☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
ALK-Positive
Roche's Ventana ALK (D5F3) CDx Assay Receives the US FDA's Approval for the Treatment of ALK-Positive NSCLC
March 9, 2021
Roche Reports Updated Data of Alecensa in P-III ALEX Study for Patients with ALK-Positive Non-Small Cell Lung Cancer
May 29, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.